Insider Trading30 Sept 2026, 05:10 pm
Sanjay Bansal Sells 70,000 Medicamen Biotech Shares
AI Summary
Mr. Sanjay Bansal, a Director at Medicamen Biotech Limited, has sold 70,000 equity shares, representing 0.51% of his total holding. Prior to the transaction, he held 1,02,813 equity shares (0.76% of total capital). After the sale, his holding reduced to 32,813 equity shares. The transaction, classified as a 'Sale' under SEBI (PIT) Regulations 2015, occurred on the market between September 28, 2026, and September 30, 2026. The total post-transaction holding is 1,05,42,440 equity shares.
Key Highlights
- Director Sanjay Bansal sold 70,000 equity shares.
- The sale represents 0.51% of his total shareholding.
- His holding decreased from 0.76% to 0.25% post-transaction.
- The transaction was conducted on the open market.
- This is a disclosure under SEBI (Prohibition of Insider Trading) Regulations.
Price Impact
More from MEDICAMEQ